Related Experiment Video

Updated: May 21, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

LDL lowering in peripheral arterial disease: are there benefits beyond reducing cardiovascular morbidity and

Amy W Pollak1, Christopher M Kramer

  • 1Department of Medicine & the Cardiovascular Imaging Center, University of Virginia Health System, University of Virginia, Lee Street, Box 800170, Charlottesville, VA 22908, USA.

Clinical Lipidology
|June 19, 2012
PubMed

Insights

Statins, used for lowering LDL cholesterol, may improve exercise performance in peripheral arterial disease patients. Further research is exploring how statins

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology

Background:

  • Peripheral arterial disease (PAD) of the lower extremities increases cardiovascular mortality risk.
  • PAD significantly reduces functional capacity due to claudication (leg pain during exercise).
  • Lipid-lowering statins are proven to prevent cardiovascular events in PAD patients.

Purpose of the Study:

  • To investigate if LDL cholesterol lowering with statins improves exercise performance in PAD patients.
  • To explore the pleiotropic effects of statins in enhancing functional capacity for claudication.
  • To understand how lipid-lowering therapy may alleviate exercise-induced symptoms in PAD.

Main Methods:

  • Review of multiple studies investigating statin therapy in PAD.
  • Analysis of data on exercise performance and functional capacity in PAD patients undergoing statin treatment.
  • Exploration of the complex pathophysiology of claudication and potential therapeutic targets.

Main Results:

  • Evidence supports statins for cardiovascular event prevention in PAD.
  • The role of statins in improving exercise performance in PAD remains under active investigation.
  • Understanding statin's pleiotropic effects is key to enhancing functional capacity.

Conclusions:

  • Lipid-lowering therapy with statins is crucial for cardiovascular risk reduction in PAD.
  • Further research is needed to elucidate the mechanisms by which statins may improve functional capacity and alleviate claudication symptoms.
  • Investigating the pleiotropic effects of statins offers potential for novel therapeutic strategies in PAD management.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...